Scientists, clinicians, and other investigators are discovering new uses for drugs previously known for different medical indications. Such “drug repurposing” (also called drug repositioning, profiling, or re-tasking) has...more
10/5/2020
/ Actavis Inc. ,
Coronavirus/COVID-19 ,
Eli Lilly ,
Intellectual Property Protection ,
Investment Opportunities ,
Investment Products ,
IP License ,
Marketing Exclusivity Periods ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Prescription Drugs ,
Treatment Method Patents
Avoiding Common IP Pitfalls: What Every Startup Needs to Know -
Startup companies often face significant risk and liability with respect to Intellectual Property (IP) on their path to success. The failure to adequately...more